Health

Results: 829-840 of 9181

Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA

PR Newswire associated0

Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026

Alkermes to Report First Quarter Financial Results on May 5, 2026

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

PR Newswire associated0

Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%

PR Newswire associated0

Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic

Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology

Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs

PR Newswire associated0

Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

d-wise Appoints 2x-CEO, ex-Labcorp Head of Software Solutions to Drive Next Phase of Strategy & Growth